U.S. Department of Health and Human Services
Staff Search  
​​

If you plan to apply, Register Early.

Registration is required at eRA Commons and grants.gov and can take 4 weeks.​

Obesity Treatment and Prevention

The Obesity Treatment and Prevention program supports research on the prevention and treatment of overweight and obesity across the lifespan.  Research focuses on critical periods for excess weight gain or high-risk populations.

Prevention research includes studies of treatment approaches to stop the initial development of overweight/obesity or to prevent additional weight or fat gain in those already overweight or obese.  These approaches include behavioral, lifestyle, or environmental interventions to improve diet, decrease sedentary behavior, and increase physical activity.  Treatment research focuses on clinical trials that evaluate different approaches to losing weight, improving BMI percentile in growing children, or maintaining weight loss.  These interventions involve behavioral, pharmacologic, and surgical approaches.

Research to understand and address psychosocial risk factors related to weight management is also supported.  For example, obesity research addressing binge eating, stress, impulsivity, and the influence of social networks might be supported if the primary aim is to improve weight management.

The program also promotes research testing environmental, policy-based, and population-based approaches to the prevention and treatment of obesity, including studies evaluating the impact of programs or policies on diet, physical activity, or obesity development.

​​​​​​​​​​​​​​​​
 

 NIDDK Staff

 
Dana K. Andersen, M.D.Observational and Investigational Clinical Research; Biomedical Devices, Surgical Interventions, and MedicationsMary Evans, Ph.D.Special Projects in Nutrition, Obesity, and Digestive Diseases; Lifestyle Interventions in Obesity; Nutrition Obesity Research Centers; Diet & Physical Activity Assessment Methodology
Mary Horlick, M.D.Clinical Bariatric Surgery; Pediatric Clinical Obesity Research
Christine Hunter, Ph.D., ABPPClinical research on behavioral treatments and prevention for obesity and diabetes; Centers for Diabetes Translational Research.Robert Kuczmarski, Dr.P.H.Obesity Prevention and Treatment

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
7/17/2014High Throughput Screening (HTS) to Discover Chemical Probes (R01) (Summary) PAR-14-284
6/25/2014NIDDK Mentored Research Scientist Development Award (K01) (Summary) PAR-14-266
6/18/2014Long-Term Outcomes of Bariatric Surgery Using Large Datasets (R01) (Summary) PAR-14-262
5/19/2014Nutrition Obesity Research Centers (NORCs) (P30) (Summary) RFA-DK-14-002
5/2/2014Administrative Supplements for Research on Dietary Supplements (Admin Supp) (Summary) PAR-14-201
View More Funding Opportunities

​The resources listed below include reagents, data, protocols, etc.  If you would like to utilize any of these resources, contact the person associated with the resource.
 

 Research Resources

 
Resource NameDescription
Hyperglycemia and Pregnancy Outcomes Follow-Up Study Consortium

The goal of this follow-up study of mothers who participated in the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study, is to determine the levels of blood sugar during pregnancy that … (Summary)

Diabetes Prevention Program
The DPP showed that lifestyle change or metformin delay the development of type 2 diabetes. The DPPOS is a long-term follow-up study of the DPP participants.
(Summary)
NIDDK Information Network

The NIDDK Information Network (dkNET), serves the needs of basic and clinical investigators by providing seamless access to large pools of data relevant to the mission of NIDDK. The goal of … (Summary)

Efficacy and Mechanisms of Glutamine Dipeptide in the Surgical Intensive Care Unit

The GLND trial is a multi-center, double-blind, placebo-controlled, intent-to-treat Phase III trial, designed to determine the effect of parenteral glutamine (GLN) dipeptide on important clinical … (Summary)

Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in … (Summary)

View Additional Research Resources

 

 NIDDK Active Trials in Obesity and Nutrition

 
View related clinical trials from ClinicalTrials.gov.

 

 Related Study Sections

 
Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.